Market research future has a cooked research report on Global Women Healthcare Market.
The Women Healthcare Market is growing at an average rate and is expected to show the
similar trend during forecast period.
Market Highlights
With the growing awareness of early diagnosis, advanced treatment and growing novel
drugs to treat the women health disorders among the patients and healthcare professionals
has supported the growth of the market. The health of women is of particular concern as in
many societies women are disadvantaged by discrimination rooted in sociocultural factors.
For instance, women and girls face increased vulnerability to HIV/AIDS.
Globally, Women Healthcare Market is dominated by several major players such as Allergan,
Amgen, Bayer, BD, Eli Lily, Merck, Pfizer, Teva Pharmaceuticals and others. APAC region
was the most benefited region due to the rising prevalence of the disease and rising number
of treatment for women associated diseases and increasing advanced devices and
therapeutics for gynecological disorders. The market for women healthcare is projected to
grow at a steady CAGR of 5.04% during the forecast period from 2017-2023.
Segmentation:
The Women Healthcare Market is segmented on the basis of indications, diagnosis and
treatment and also on the basis of end users. Based on the indications, the market has been
segmented as postmenopausal osteoporosis, infertility, reproductive health management,
polycystic ovary syndrome, gynecologic cancer and others. Gynecologic cancer segment has
been further divided into breast, ovarian or other types of cancer. On the basis of diagnosis
the market has been segmented as bone densitometry, diagnostic imaging tests, biopsies,
ovulation testing and others. Similarly, on the basis of treatment the market has been
classified as therapeutics, surgeries and others. Lastly on the basis of end users the market
has been further classified into hospitals & clinics, gynecology centers, research institutes,
and others
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/3121 .
Global Women Healthcare Market Players:
Market players profiled in the report are Allergan plc. (Ireland), Amgen (California), Bayer A
G (Germany), Becton Dickinson and Company (U.S.), Eli Lilly Company (U.S.), Merck & Co.,
Inc., (U.S.), Pfizer Inc., (U.S.), and Teva Pharmaceuticals (Israel).
The Women Healthcare Market has turned into a critical factor in the Global Healthcare
industry. Through extensive research it is found out that the market players are investing in
the research and development of new and novel drugs for the treatment of various women
health disorders and receiving FDA approvals for the drugs and devices in the women
healthcare market. The key players involved in this FDA approvals are Bayer AG, Becton,
Dickinson and Company, Pfizer Inc. and Teva Pharmaceuticals. FDA approvals (32%) is the
most widely opted strategy which was adopted by the key market players. The number of
key market player involved in Clinical Trials (23%), Product Launch (18%), Awards &
Recognition (14%), Agreements & Collaboration (9%) and others are comparatively low, the
market players which were involved in Clinical Trials are Allergan, Bayer, Eli Lily, AbbVie and
others in the Global Women Healthcare Market.
Regional analysis
On the basis of region the market is segmented into North America, Europe, Asia-Pacific and
Middle East and Africa. North America was commands the largest market share which is
expected to reach USD 21,782.6 million by 2023 due to well-developed economy and
initiatives taken to promote women healthcare in the region. On the other hand factors such
as high cost of diagnosis and treatments are restricting the market growth in the Middle
East & African region, while Asia-Pacific countries are expected to be the fastest growing
region with a CAGR of 5.46% from 2017-2023.
Apply for Discount @ https://www.marketresearchfuture.com/check-discount/3121 .
Table of Contents
1 Report Prologue